The Healthware Ventures portfolio company 1000Farmacie, a leading Italian e-pharmacy marketplace, has announced the successful completion of its second tranche of Series A
The EMA's human medicines committee has recommended against approval of Eisai and Biogen's Alzheimer's disease therapy Leqembi, after regulators in the US, China and Japan gave a green ligh